Cytosorbents Corporation CTSO
$5.75
$0.020.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.21M | -11.85M | -8.20M | -10.27M | -9.87M |
| Total Depreciation and Amortization | 1.54M | 1.60M | 1.63M | 1.67M | 1.70M |
| Total Amortization of Deferred Charges | 1.01M | 921.00K | 820.00K | 762.00K | 762.00K |
| Total Other Non-Cash Items | 5.57M | -1.37M | -5.60M | -949.00K | -3.30M |
| Change in Net Operating Assets | 949.00K | 621.00K | -1.03M | -1.11M | 929.00K |
| Cash from Operations | -9.15M | -10.07M | -12.38M | -9.89M | -9.78M |
| Capital Expenditure | -150.00K | -173.00K | -164.00K | -125.00K | -260.00K |
| Sale of Property, Plant, and Equipment | 161.00K | 102.00K | 76.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -286.00K | -343.00K | -327.00K | -123.00K | -342.00K |
| Cash from Investing | -275.00K | -414.00K | -415.00K | -248.00K | -602.00K |
| Total Debt Issued | 2.48M | 2.48M | 2.48M | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 0.00 | 0.00 | 6.83M | 7.00M | 7.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -41.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -58.00K |
| Cash from Financing | 2.48M | 2.48M | 9.31M | 7.00M | 6.90M |
| Foreign Exchange rate Adjustments | 1.15M | 1.23M | 1.49M | 33.00K | 264.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.79M | -6.78M | -1.99M | -3.11M | -3.22M |